Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

William Messer

14PUBLICATIONS
83CO-AUTHORS
Medical virologyInnate immunityHorticultural crop protection (incl. pests, diseases and weeds)Predictive and prognostic markersMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

Sort by Publication Date:
|Mar 17, 2026
Empiric azithromycin alters the upper respiratory microbiome and resistome without anti-inflammatory benefit in COVID-19.

Abigail Glascock, Cole Maguire, Hoang Van Phan

|Feb 23, 2026
Author Correction: Machine learning models predict long COVID outcomes based on baseline clinical and immunologic factors.

Naresh Doni Jayavelu, Hady Samaha, Sonia Tandon Wimalasena

|Feb 11, 2026
New insights into an old vaccine: potency and breadth of neutralizing antibodies elicited by the yellow fever vaccine 17D are boosted by heterologous Orthoflavivirus infection.

Felicity J Coulter, Courtney A Micheletti, Abram E Estrada

|Jan 03, 2026
Machine learning models predict long COVID outcomes based on baseline clinical and immunologic factors.

Naresh Doni Jayavelu, Hady Samaha, Sonia Tandon Wimalasena

|Aug 06, 2025
New insights into an old vaccine: potency and breadth of neutralizing antibodies elicited by the yellow fever vaccine 17D are boosted by heterologous <i>Orthoflavivirus</i> infection.

Felicity J Coulter, Abram E Estrada, Courtney A Micheletti

|Jun 30, 2025
Empiric Azithromycin in COVID-19 Impacts the Respiratory Microbiome and Antimicrobial Resistome without Anti-inflammatory Benefit.

Charles Langelier, Abigail Glascock, Cole Maguire

Pageof 3

Frequent Collaborators

7 joint publications

Al Ozonoff

7 joint publications

Ofer Levy

6 joint publications

Florian Krammer

6 joint publications

Steven Kleinstein

6 joint publications

Matthew C Altman

6 joint publications

Lauren I R Ehrlich

6 joint publications

Patrice M Becker

6 joint publications

Holden T Maecker

6 joint publications

Charles R Langelier

6 joint publications

Joann Diray-Arce

Frequent Collaborators

7 joint publications

Al Ozonoff

7 joint publications

Ofer Levy

6 joint publications

Florian Krammer

6 joint publications

Steven Kleinstein

Top Related Videos

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes
03:53

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes

Published on : Apr 19, 2024

1.2K
Constructing and Visualizing Models using Mime-based Machine-learning Framework
06:19

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on : Jul 22, 2025

2.6K
In Vitro ELISA Test to Evaluate Rabies Vaccine Potency
09:04

In Vitro ELISA Test to Evaluate Rabies Vaccine Potency

Published on : May 11, 2020

13.4K
See more related videos

Top Related Videos

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes
03:53

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes

Published on : Apr 19, 2024

1.2K
Constructing and Visualizing Models using Mime-based Machine-learning Framework
06:19

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on : Jul 22, 2025

2.6K
In Vitro ELISA Test to Evaluate Rabies Vaccine Potency
09:04

In Vitro ELISA Test to Evaluate Rabies Vaccine Potency

Published on : May 11, 2020

13.4K
See more related videos